tiprankstipranks
Trending News
More News >
Ezaki Glico Co., Ltd. (JP:2206)
:2206

Ezaki Glico Co., Ltd. (2206) AI Stock Analysis

Compare
3 Followers

Top Page

JP:2206

Ezaki Glico Co., Ltd.

(2206)

Select Model
Select Model
Select Model
Neutral 65 (OpenAI - 5.2)
Rating:65Neutral
Price Target:
¥6,297.00
▲(25.89% Upside)
Action:ReiteratedDate:02/18/26
The score is driven by strong financial stability from a conservative balance sheet and supportive technical momentum, but is held back by deteriorating profitability, uneven cash-flow consistency, and a demanding valuation (high P/E with only a modest dividend yield).
Positive Factors
Conservative balance sheet
Extremely low leverage and a conservative capital structure materially reduce refinancing and solvency risk. Over the next 2–6 months this durability gives flexibility to absorb cost shocks, fund targeted capex or M&A selectively, and preserve investment in brands without pressure to deleverage.
Return to revenue growth
Resumption of top-line growth indicates product demand recovery and supports scale economics in manufacturing and distribution. Sustained revenue expansion can underpin margin recovery, steady cash generation, and justify continued brand investment over a multi-quarter horizon.
Strong branded portfolio & retail reach
Well-known consumer brands and deep retail placement create durable shelf presence and customer loyalty. This structural advantage helps new product rollouts, seasonal promotions, and steady repeat sales, supporting predictable core volumes and long-term market positioning.
Negative Factors
Profitability has materially weakened
Rapid margin erosion signals persistent cost inflation or pricing pressure that compresses operating leverage. If structural, lower margins reduce reinvestment capacity, constrain cash available for strategic initiatives, and weaken earnings resiliency across economic cycles.
Volatile cash generation
Large swings in operating and free cash flow undermine predictability for dividends, capex and M&A. Inconsistent cash conversion increases reliance on timing or one-off items to fund operations, making long-term planning and shareholder-return programs less reliable.
Low and falling return on equity
Declining ROE despite a conservative balance sheet points to weak earnings quality and capital efficiency. Low ROE limits the company's ability to generate attractive shareholder returns and may force management to choose between growth investments and improving capital productivity.

Ezaki Glico Co., Ltd. (2206) vs. iShares MSCI Japan ETF (EWJ)

Ezaki Glico Co., Ltd. Business Overview & Revenue Model

Company DescriptionEzaki Glico Co., Ltd. (2206) is a leading Japanese food company, best known for its confectionery products, particularly its iconic Pocky snack and various other snacks, ice creams, and dairy products. Founded in 1922, Glico operates across multiple sectors, including the food and beverage industry, focusing on innovation and quality. The company has expanded its product offerings to include health-oriented snacks and nutritional products, catering to a diverse consumer base both domestically and internationally.
How the Company Makes MoneyEzaki Glico generates revenue primarily through the sale of its confectionery products, including biscuits, chocolates, and snacks, which form the bulk of its sales. The company also earns revenue from its ice cream and dairy products, which have seen growing demand. Glico has established significant partnerships with retailers and distributors, enhancing its market reach. Additionally, the company invests in marketing and promotional activities to boost brand awareness and drive sales. Through continuous innovation in product development and expanding its international presence, Glico aims to capture new markets and increase its overall revenue streams.

Ezaki Glico Co., Ltd. Financial Statement Overview

Summary
Strong balance sheet strength (very low leverage; Balance Sheet Score 86) supports financial stability, but earnings quality has weakened as margins and net profit declined materially despite revenue returning to growth (Income Statement Score 62). Cash flow improved in 2025 yet remains inconsistent given prior weak/negative free cash flow periods (Cash Flow Score 58).
Income Statement
62
Positive
Revenue returned to growth in 2025 (+5.8% YoY) after a flat 2024, but profitability has weakened meaningfully: net margin fell to ~1.4% in 2025 from ~2.5% in 2024 and ~4.2% in 2023, and operating margin similarly compressed (~2.4% in 2025 vs ~3.7% in 2024). Gross margin also stepped down versus prior years, pointing to cost/price pressure. Overall: solid top-line stability for a packaged foods profile, but the recent earnings/margin downshift is a clear negative.
Balance Sheet
86
Very Positive
Balance sheet is very conservative, highlighted by extremely low reported leverage in 2024–2025 (debt-to-equity near zero), alongside steady growth in equity and assets. Return on equity has been modest and has trended down with weaker earnings (from ~5–6% earlier years to ~3% in 2024), which is the main trade-off of the strong capital position. Overall: high financial stability with limited balance-sheet risk.
Cash Flow
58
Neutral
Cash generation is volatile. 2025 shows a strong rebound with operating cash flow of ~¥29.4B and free cash flow of ~¥19.3B, but 2024 was weak (operating cash flow ~¥1.8B and negative free cash flow ~-¥15.7B), and 2022 also had negative free cash flow. While recent improvement is encouraging, the swingy free-cash-flow profile reduces confidence in consistency.
BreakdownTTMDec 2025Dec 2024Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue341.60B361.39B331.13B332.59B303.92B338.57B
Gross Profit128.29B127.56B127.67B123.85B110.75B158.03B
EBITDA29.86B28.28B29.06B34.05B27.93B35.09B
Net Income8.19B5.04B8.11B14.13B8.10B13.52B
Balance Sheet
Total Assets369.01B394.13B377.77B395.74B369.05B356.74B
Cash, Cash Equivalents and Short-Term Investments51.84B68.63B60.24B97.20B91.93B102.25B
Total Debt7.16B154.00M165.00M30.00B30.02B30.35B
Total Liabilities102.36B115.59B105.18B132.63B124.30B115.57B
Stockholders Equity266.05B277.90B272.00B262.54B244.29B240.79B
Cash Flow
Free Cash Flow0.0019.26B-15.66B9.69B-8.89B4.89B
Operating Cash Flow0.0029.39B1.81B28.06B16.80B28.65B
Investing Cash Flow0.00-16.08B-10.26B-8.61B-20.14B-29.19B
Financing Cash Flow0.00-6.92B-39.15B-6.18B-10.28B-4.86B

Ezaki Glico Co., Ltd. Technical Analysis

Technical Analysis Sentiment
Positive
Last Price5002.00
Price Trends
50DMA
5636.25
Positive
100DMA
5394.35
Positive
200DMA
5057.66
Positive
Market Momentum
MACD
120.44
Negative
RSI
69.38
Neutral
STOCH
73.40
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:2206, the sentiment is Positive. The current price of 5002 is below the 20-day moving average (MA) of 5876.00, below the 50-day MA of 5636.25, and below the 200-day MA of 5057.66, indicating a bullish trend. The MACD of 120.44 indicates Negative momentum. The RSI at 69.38 is Neutral, neither overbought nor oversold. The STOCH value of 73.40 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for JP:2206.

Ezaki Glico Co., Ltd. Peers Comparison

Overall Rating
UnderperformOutperform
Sector (62)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
73
Outperform
¥485.53B16.8710.81%2.56%3.87%29.64%
66
Neutral
¥398.86B23.848.27%1.95%5.82%-13.40%
65
Neutral
¥395.13B76.682.66%1.64%8.40%-23.50%
64
Neutral
¥339.28B21.602.61%6.54%15.08%
63
Neutral
¥247.07B17.962.11%3.69%-50.13%
62
Neutral
$20.33B14.63-3.31%3.23%1.93%-12.26%
59
Neutral
¥436.07B31.872.42%2.33%-8.76%
* Consumer Defensive Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
JP:2206
Ezaki Glico Co., Ltd.
6,091.00
1,614.41
36.06%
JP:2229
CALBEE
3,089.00
297.94
10.67%
JP:1332
Nippon Suisan Kaisha
1,560.00
715.90
84.81%
JP:2264
Morinaga Milk Industry Co., Ltd.
4,916.00
2,025.01
70.05%
JP:2296
Itoham Yonekyu Holdings, Inc.
6,400.00
2,870.08
81.31%
JP:2811
Kagome Co., Ltd.
2,869.00
-29.11
-1.00%

Ezaki Glico Co., Ltd. Corporate Events

Ezaki Glico Board Rejects Activist Shareholder’s Push for Director Changes and Potential Privatization
Feb 13, 2026

Ezaki Glico has disclosed that it received a shareholder proposal from LONGCHAMP SICAV, represented by Dalton Investments, seeking to nominate two outside directors, authorize large-scale share buybacks, revise restricted stock compensation, and amend the articles of incorporation to reinforce management awareness of capital costs and share price. After review by its board and its majority-outside Nomination and Compensation Committee, Glico’s directors resolved to oppose the director nominations, arguing the current board already has appropriate skill balance and diversity to execute its long-term strategy and mid-term management plan.

The board also expressed concern that the proposing shareholder is prioritizing short-term share-price gains and a potential take-private transaction, including a management buyout structure involving a private equity fund and rollover investment, which Glico believes could create conflicts of interest with general shareholders. Citing past interactions and public comments by Dalton’s chief investment officer about aiming to take Glico private, the company warned that the proposal could steer it toward privatization on terms misaligned with its focus on medium- to long-term value creation and the common interests of all shareholders.

The most recent analyst rating on (JP:2206) stock is a Hold with a Yen6199.00 price target. To see the full list of analyst forecasts on Ezaki Glico Co., Ltd. stock, see the JP:2206 Stock Forecast page.

Ezaki Glico Launches ¥25 Billion Share Buyback and Cancellation Plan
Feb 13, 2026

Ezaki Glico has authorized a substantial share buyback of up to 4.6 million common shares, representing 7.23% of its outstanding stock excluding treasury shares, with a maximum outlay of ¥25 billion. The purchases will be executed on the Tokyo Stock Exchange between March 1 and December 30, 2026, and all acquired shares are scheduled to be cancelled, signaling a commitment to shareholder returns and balance-sheet optimization.

Management said the move is intended to enhance shareholder returns and provide flexibility in capital policy amid a changing operating environment, with part of the funding to come from borrowings. Given existing treasury stock of about 4.8 million shares at the end of 2025, the additional buyback and planned cancellation are likely to tighten the share float and may support per-share metrics, potentially improving the company’s market valuation and capital efficiency.

The most recent analyst rating on (JP:2206) stock is a Hold with a Yen6199.00 price target. To see the full list of analyst forecasts on Ezaki Glico Co., Ltd. stock, see the JP:2206 Stock Forecast page.

Ezaki Glico Books ¥3.4 Billion Impairment on Powdered Baby Milk Assets
Feb 13, 2026

Ezaki Glico announced it has recorded a fixed asset impairment loss related to facilities used in its powdered baby milk business, a part of its Dairy Business. After reassessing the future recoverability of these assets under Japan’s impairment accounting standards, the company wrote down their book value to recoverable levels, resulting in an extraordinary loss of ¥3,393 million in its fiscal year ended December 31, 2025.

The impairment reflects management’s assessment of the business environment and future prospects for the powdered baby milk segment, suggesting weaker expected returns from this line. This extraordinary loss has been incorporated into the company’s consolidated financial results for the 2025 fiscal year and may weigh on reported profitability, signaling strategic and earnings implications for stakeholders monitoring Ezaki Glico’s dairy operations.

The most recent analyst rating on (JP:2206) stock is a Hold with a Yen6199.00 price target. To see the full list of analyst forecasts on Ezaki Glico Co., Ltd. stock, see the JP:2206 Stock Forecast page.

Ezaki Glico Posts Higher Sales but Profit Slump for FY2025 Amid Margin Pressure
Feb 13, 2026

Ezaki Glico reported a 9.1% increase in net sales to ¥361.4 billion for the fiscal year ended December 31, 2025, but operating profit fell 21.0% and profit attributable to owners of parent dropped 37.9%. Earnings per share declined to ¥79.12, reflecting margin pressure despite higher revenues, while the operating profit margin narrowed to 2.4% and ordinary profit to total asset ratio slipped to 3.0%.

Total assets rose to ¥394.1 billion and net assets to ¥278.5 billion, with a still-solid shareholders’ equity ratio of 70.5% and higher net assets per share of ¥4,365.35. Cash flows from operating activities improved sharply to ¥27.3 billion, cash and cash equivalents increased to ¥64.7 billion, and reduced cash outflows from financing activities suggest a stabilizing balance sheet despite weaker profitability, with implications for dividends and future investment capacity.

The most recent analyst rating on (JP:2206) stock is a Hold with a Yen6199.00 price target. To see the full list of analyst forecasts on Ezaki Glico Co., Ltd. stock, see the JP:2206 Stock Forecast page.

Ezaki Glico Revises 2025 Financial Forecasts Due to Product Recall and Sluggish Sales
Dec 17, 2025

Ezaki Glico Co., Ltd. has revised its full-year financial forecast for 2025, citing a reduction in expected net sales and profits due to a chocolate recall and sluggish sales in its ice cream and chilled products sectors. Despite these downward revisions, the company has maintained its dividend forecasts, indicating a commitment to shareholder returns amidst operational challenges.

The most recent analyst rating on (JP:2206) stock is a Hold with a Yen5844.00 price target. To see the full list of analyst forecasts on Ezaki Glico Co., Ltd. stock, see the JP:2206 Stock Forecast page.

Ezaki Glico Initiates Voluntary Recall of Chocolate Products Due to Flavor Issues
Dec 8, 2025

Ezaki Glico Co., Ltd. has announced a voluntary recall of 20 chocolate products, including popular items like Pocky Chocolate, due to unintended flavor variations caused by spice contamination during warehouse renovations. While there are no safety concerns, the company is taking steps to prevent future occurrences and is assessing the financial impact of this recall on its fiscal year ending December 2025.

The most recent analyst rating on (JP:2206) stock is a Hold with a Yen5844.00 price target. To see the full list of analyst forecasts on Ezaki Glico Co., Ltd. stock, see the JP:2206 Stock Forecast page.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Feb 18, 2026